Covid-19, clinical trials, and the new normal: data shows decentralisation is here to stay

Many new approaches to clinical research were pressed forward during the Covid-19 pandemic, most notably the move towards decentralisation. As we finally enter the ‘new normal’, Pharmaceutical Technology explores what looks like a short-term fix and what’s here to stay.